COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott Laboratories | Common | 002824100 | 66,749 | 1,250,920 | SH | | SOLE | | 1,250,920 | 0 | 0 |
AbbVie Inc. | Common | 00287Y109 | 9,287 | 104,513 | SH | | SOLE | | 104,513 | 0 | 0 |
AC Immune SA | Shares | H00263105 | 462 | 40,919 | SH | | SOLE | | 40,919 | 0 | 0 |
Acadia Healthcare Company, Inc. | Common | 00404A109 | 13,010 | 272,400 | SH | | SOLE | | 272,400 | 0 | 0 |
Accelerate Diagnostics, Inc. | Common | 00430H102 | 3,368 | 150,000 | SH | | SOLE | | 150,000 | 0 | 0 |
Acceleron Pharma Inc. | Common | 00434H108 | 2,226 | 59,654 | SH | | SOLE | | 59,654 | 0 | 0 |
Achillion Pharmaceuticals, Inc. | Common | 00448Q201 | 2,766 | 616,000 | SH | | SOLE | | 616,000 | 0 | 0 |
Adaptimmune Therapeutics plc | Sponsored ADR | 00653A107 | 7,661 | 935,368 | SH | | SOLE | | 935,368 | 0 | 0 |
Adverum Biotechnologies, Inc. | Common | 00773U108 | 1,095 | 300,078 | SH | | SOLE | | 300,078 | 0 | 0 |
Aegerion Pharmaceuticals, Inc. | Note 2.00% 5/15/19 | 00767EAB8 | 10,303 | 13,000,000 | PRN | | SOLE | | 13,000,000 | 0 | 0 |
Affimed N.V. | Common | N01045108 | 3,162 | 1,405,324 | SH | | SOLE | | 1,405,324 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 105,344 | 750,905 | SH | | SOLE | | 750,905 | 0 | 0 |
Allergan plc | Shares | G0177J108 | 69,474 | 338,979 | SH | | SOLE | | 338,979 | 0 | 0 |
Allergan plc | Preferred Convertible Series A | G0177J116 | 3,689 | 5,000 | SH | | SOLE | | 5,000 | 0 | 0 |
Alliqua BioMedical, Inc. | Common | 019621200 | 602 | 1,650,000 | SH | | SOLE | | 1,650,000 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 13,507 | 114,966 | SH | | SOLE | | 114,966 | 0 | 0 |
Amarin Corporation plc | Sponsored ADR | 023111206 | 3,347 | 956,300 | SH | | SOLE | | 956,300 | 0 | 0 |
AmerisourceBergen Corporation | Common | 03073E105 | 23,847 | 288,187 | SH | | SOLE | | 288,187 | 0 | 0 |
Amgen Inc. | Common | 031162100 | 115,650 | 620,274 | SH | | SOLE | | 620,274 | 0 | 0 |
Amicus Therapeutics, Inc. | Common | 03152W109 | 4,154 | 275,494 | SH | | SOLE | | 275,494 | 0 | 0 |
Anthem, Inc. | Common | 036752103 | 8,529 | 44,918 | SH | | SOLE | | 44,918 | 0 | 0 |
ARCA biopharma, Inc. | Common | 00211Y407 | 892 | 811,227 | SH | | SOLE | | 811,227 | 0 | 0 |
Ardelyx, Inc. | Common | 039697107 | 3,580 | 639,370 | SH | | SOLE | | 639,370 | 0 | 0 |
argenx SE | Sponsored ADR | 04016X101 | 1,683 | 75,000 | SH | | SOLE | | 75,000 | 0 | 0 |
AstraZeneca PLC | Sponsored ADR | 046353108 | 14,995 | 442,600 | SH | | SOLE | | 442,600 | 0 | 0 |
Auris Medical Holding AG | Common | H03579101 | 635 | 774,504 | SH | | SOLE | | 774,504 | 0 | 0 |
Avadel Pharmaceuticals plc | Sponsored ADR | 05337M104 | 6,555 | 624,288 | SH | | SOLE | | 624,288 | 0 | 0 |
AveXis, Inc. | Common | 05366U100 | 967 | 10,000 | SH | | SOLE | | 10,000 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | Common | 079481107 | 693 | 60,000 | SH | | SOLE | | 60,000 | 0 | 0 |
BioCryst Pharmaceuticals, Inc. | Common | 09058V103 | 1,694 | 323,255 | SH | | SOLE | | 323,255 | 0 | 0 |
Biogen Inc. | Common | 09062X103 | 153,305 | 489,604 | SH | | SOLE | | 489,604 | 0 | 0 |
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 46,697 | 501,745 | SH | | SOLE | | 501,745 | 0 | 0 |
bluebird bio, Inc. | Common | 09609G100 | 1,823 | 13,273 | SH | | SOLE | | 13,273 | 0 | 0 |
Cardinal Health, Inc. | Common | 14149Y108 | 5,126 | 76,600 | SH | | SOLE | | 76,600 | 0 | 0 |
Cascadian Therapeutics, Inc. | Common | 14740B606 | 1,856 | 453,900 | SH | | SOLE | | 453,900 | 0 | 0 |
Celgene Corporation | Common | 151020104 | 202,329 | 1,387,525 | SH | | SOLE | | 1,387,525 | 0 | 0 |
Celldex Therapeutics, Inc. | Common | 15117B103 | 303 | 105,800 | SH | | SOLE | | 105,800 | 0 | 0 |
Cellectis S.A. | Sponsored ADR | 15117K103 | 8,827 | 310,250 | SH | | SOLE | | 310,250 | 0 | 0 |
Centene Corporation | Common | 15135B101 | 22,272 | 230,158 | SH | | SOLE | | 230,158 | 0 | 0 |
Charles River Laboratories International, Inc. | Common | 159864107 | 13,729 | 127,100 | SH | | SOLE | | 127,100 | 0 | 0 |
Cidara Therapeutics, Inc. | Common | 171757107 | 2,320 | 286,472 | SH | | SOLE | | 286,472 | 0 | 0 |
Cigna Corporation | Common | 125509109 | 18,694 | 100,002 | SH | | SOLE | | 100,002 | 0 | 0 |
Clovis Oncology, Inc. | Common | 189464100 | 6,213 | 75,400 | SH | | SOLE | | 75,400 | 0 | 0 |
Coherus BioSciences, Inc. | Common | 19249H103 | 1,202 | 90,000 | SH | | SOLE | | 90,000 | 0 | 0 |
Community Health Systems, Inc. | Common | 203668108 | 1,566 | 203,935 | SH | | SOLE | | 203,935 | 0 | 0 |
CVS Health Corporation | Common | 126650100 | 33,495 | 411,891 | SH | | SOLE | | 411,891 | 0 | 0 |
CymaBay Therapeutics, Inc. | Common | 23257D103 | 1,692 | 209,962 | SH | | SOLE | | 209,962 | 0 | 0 |
CytomX Therapeutics, Inc. | Common | 23284F105 | 9,632 | 530,092 | SH | | SOLE | | 530,092 | 0 | 0 |
Dermira, Inc. | Common | 24983L104 | 10,716 | 396,900 | SH | | SOLE | | 396,900 | 0 | 0 |
DexCom, Inc. | Common | 252131107 | 5,279 | 107,900 | SH | | SOLE | | 107,900 | 0 | 0 |
Diplomat Pharmacy, Inc. | Common | 25456K101 | 9,562 | 461,712 | SH | | SOLE | | 461,712 | 0 | 0 |
Edwards Lifesciences Corporation | Common | 28176E108 | 10,647 | 97,400 | SH | | SOLE | | 97,400 | 0 | 0 |
Egalet Corporation | Note 5.50% 4/1/20 | 28226BAB0 | 3,601 | 7,000,000 | PRN | | SOLE | | 7,000,000 | 0 | 0 |
Eiger BioPharmaceuticals, Inc. | Common | 28249U105 | 341 | 31,028 | SH | | SOLE | | 31,028 | 0 | 0 |
Eli Lilly & Company | Common | 532457108 | 33,198 | 388,100 | SH | | SOLE | | 388,100 | 0 | 0 |
Endo International plc | Shares | G30401106 | 7,833 | 914,548 | SH | | SOLE | | 914,548 | 0 | 0 |
Entellus Medical, Inc. | Common | 29363K105 | 6,304 | 341,471 | SH | | SOLE | | 341,471 | 0 | 0 |
Epizyme, Inc. | Common | 29428V104 | 8,687 | 456,000 | SH | | SOLE | | 456,000 | 0 | 0 |
Evolent Health, Inc. | Class A | 30050B101 | 2,181 | 122,500 | SH | | SOLE | | 122,500 | 0 | 0 |
Exelixis, Inc. | Common | 30161Q104 | 9,421 | 388,822 | SH | | SOLE | | 388,822 | 0 | 0 |
Express Scripts Holding Company | Common | 30219G108 | 5,351 | 84,500 | SH | | SOLE | | 84,500 | 0 | 0 |
Foamix Pharmaceuticals Ltd. | Shares | M46135105 | 5,164 | 930,398 | SH | | SOLE | | 930,398 | 0 | 0 |
Galapagos NV | Sponsored ADR | 36315X101 | 1,933 | 19,000 | SH | | SOLE | | 19,000 | 0 | 0 |
GenMark Diagnostics, Inc. | Common | 372309104 | 2,838 | 294,749 | SH | | SOLE | | 294,749 | 0 | 0 |
Gilead Sciences, Inc. | Common | 375558103 | 226,948 | 2,801,131 | SH | | SOLE | | 2,801,131 | 0 | 0 |
Glaukos Corporation | Common | 377322102 | 2,102 | 63,707 | SH | | SOLE | | 63,707 | 0 | 0 |
GlaxoSmithKline plc | Shares | 37733W105 | 14,575 | 359,000 | SH | | SOLE | | 359,000 | 0 | 0 |
Global Blood Therapeutics, Inc. | Common | 37890U108 | 1,941 | 62,500 | SH | | SOLE | | 62,500 | 0 | 0 |
Global Medical REIT Inc. | Common | 37954A204 | 659 | 73,400 | SH | | SOLE | | 73,400 | 0 | 0 |
HCA Healthcare, Inc. | Common | 40412C101 | 7,580 | 95,232 | SH | | SOLE | | 95,232 | 0 | 0 |
HCP, Inc. | Common | 40414L109 | 1,266 | 45,500 | SH | | SOLE | | 45,500 | 0 | 0 |
Healthcare Realty Trust Incorporated | Common | 421946104 | 2,199 | 68,000 | SH | | SOLE | | 68,000 | 0 | 0 |
Healthcare Trust of America, Inc. | Class A | 42225P501 | 1,371 | 46,000 | SH | | SOLE | | 46,000 | 0 | 0 |
Henry Schein, Inc. | Common | 806407102 | 5,149 | 62,800 | SH | | SOLE | | 62,800 | 0 | 0 |
Horizon Pharma plc | Shares | G4617B105 | 2,066 | 162,900 | SH | | SOLE | | 162,900 | 0 | 0 |
Humana Inc. | Common | 444859102 | 30,400 | 124,781 | SH | | SOLE | | 124,781 | 0 | 0 |
IDEXX Laboratories, Inc. | Common | 45168D104 | 20,579 | 132,352 | SH | | SOLE | | 132,352 | 0 | 0 |
Illumina, Inc. | Common | 452327109 | 63,085 | 316,691 | SH | | SOLE | | 316,691 | 0 | 0 |
Impax Laboratories, Inc. | Common | 45256B101 | 2,524 | 124,335 | SH | | SOLE | | 124,335 | 0 | 0 |
Incyte Corporation | Common | 45337C102 | 80,933 | 693,275 | SH | | SOLE | | 693,275 | 0 | 0 |
Innoviva, Inc. | Common | 45781M101 | 3,513 | 248,803 | SH | | SOLE | | 248,803 | 0 | 0 |
Intercept Pharmaceuticals, Inc. | Common | 45845P108 | 7,151 | 123,200 | SH | | SOLE | | 123,200 | 0 | 0 |
Intercept Pharmaceuticals, Inc. | Note 3.250% 7/1/23 | 45845PAA6 | 5,330 | 6,900,000 | PRN | | SOLE | | 6,900,000 | 0 | 0 |
Jazz Pharmaceuticals plc | Shares | G50871105 | 40,060 | 273,916 | SH | | SOLE | | 273,916 | 0 | 0 |
Johnson & Johnson | Common | 478160104 | 103,869 | 798,932 | SH | | SOLE | | 798,932 | 0 | 0 |
Juno Therapeutics, Inc. | Common | 48205A109 | 2,553 | 56,900 | SH | | SOLE | | 56,900 | 0 | 0 |
Karyopharm Therapeutics Inc. | Common | 48576U106 | 8,308 | 756,679 | SH | | SOLE | | 756,679 | 0 | 0 |
LTC Properties, Inc. | Common | 502175102 | 6,399 | 136,212 | SH | | SOLE | | 136,212 | 0 | 0 |
Mallinckrodt plc | Shares | G5785G107 | 2,313 | 61,900 | SH | | SOLE | | 61,900 | 0 | 0 |
McKesson Corporation | Common | 58155Q103 | 21,936 | 142,800 | SH | | SOLE | | 142,800 | 0 | 0 |
Medical Properties Trust, Inc. | Common | 58463J304 | 13,231 | 1,007,717 | SH | | SOLE | | 1,007,717 | 0 | 0 |
Medtronic plc | Shares | G5960L103 | 45,132 | 580,326 | SH | | SOLE | | 580,326 | 0 | 0 |
Merck & Co., Inc. | Common | 58933Y105 | 94,335 | 1,473,295 | SH | | SOLE | | 1,473,295 | 0 | 0 |
Merus B.V. | Common | N5749R100 | 9,521 | 479,150 | SH | | SOLE | | 479,150 | 0 | 0 |
Momenta Pharmaceuticals, Inc. | Common | 60877T100 | 2,829 | 152,900 | SH | | SOLE | | 152,900 | 0 | 0 |
Mylan N.V. | Shares | N59465109 | 50,290 | 1,603,112 | SH | | SOLE | | 1,603,112 | 0 | 0 |
Myovant Sciences Ltd. | Common | G637AM102 | 6,188 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
NanoString Technologies, Inc. | Common | 63009R109 | 1,834 | 113,500 | SH | | SOLE | | 113,500 | 0 | 0 |
Natera, Inc. | Common | 632307104 | 6,261 | 485,758 | SH | | SOLE | | 485,758 | 0 | 0 |
Neurocrine Biosciences, Inc. | Common | 64125C109 | 34,468 | 562,467 | SH | | SOLE | | 562,467 | 0 | 0 |
Nevro Corp. | Common | 64157F103 | 17,687 | 194,621 | SH | | SOLE | | 194,621 | 0 | 0 |
New Senior Investment Group Inc. | Common | 648691103 | 5,197 | 567,997 | SH | | SOLE | | 567,997 | 0 | 0 |
Novartis AG | Sponsored ADR | 66987V109 | 34,225 | 398,662 | SH | | SOLE | | 398,662 | 0 | 0 |
Novavax, Inc. | Common | 670002104 | 651 | 571,000 | SH | | SOLE | | 571,000 | 0 | 0 |
Novo Nordisk A/S | Sponsored ADR | 670100205 | 3,544 | 73,600 | SH | | SOLE | | 73,600 | 0 | 0 |
NuVasive, Inc. | Common | 670704105 | 8,961 | 161,576 | SH | | SOLE | | 161,576 | 0 | 0 |
Omega Healthcare Investors, Inc. | Common | 681936100 | 14,634 | 458,616 | SH | | SOLE | | 458,616 | 0 | 0 |
Ovid Therapeutics Inc. | Common | 690469101 | 1,393 | 162,537 | SH | | SOLE | | 162,537 | 0 | 0 |
Perrigo Company plc | Shares | G97822103 | 3,157 | 37,300 | SH | | SOLE | | 37,300 | 0 | 0 |
Pfizer Inc. | Common | 717081103 | 28,920 | 810,087 | SH | | SOLE | | 810,087 | 0 | 0 |
Physicians Realty Trust | Common | 71943U104 | 9,409 | 530,672 | SH | | SOLE | | 530,672 | 0 | 0 |
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 16,344 | 2,837,573 | SH | | SOLE | | 2,837,573 | 0 | 0 |
PRA Health Sciences, Inc. | Common | 69354M108 | 7,769 | 102,000 | SH | | SOLE | | 102,000 | 0 | 0 |
Protagonist Therapeutics, Inc. | Common | 74366E102 | 138 | 7,822 | SH | | SOLE | | 7,822 | 0 | 0 |
Puma Biotechnology, Inc. | Common | 74587V107 | 12,633 | 105,495 | SH | | SOLE | | 105,495 | 0 | 0 |
Quorum Health Corporation | Shares | 74909E106 | 123 | 23,725 | SH | | SOLE | | 23,725 | 0 | 0 |
Quotient Limited | Common | G73268107 | 586 | 118,861 | SH | | SOLE | | 118,861 | 0 | 0 |
Ra Pharmaceuticals, Inc. | Common | 74933V108 | 5,779 | 395,818 | SH | | SOLE | | 395,818 | 0 | 0 |
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 76,241 | 170,516 | SH | | SOLE | | 170,516 | 0 | 0 |
The RMR Group Inc. | Class A | 74967R106 | 382 | 7,441 | SH | | SOLE | | 7,441 | 0 | 0 |
Sabra Health Care REIT, Inc. | Common | 78573L106 | 12,089 | 550,990 | SH | | SOLE | | 550,990 | 0 | 0 |
Sanofi | Sponsored ADR | 80105N105 | 8,957 | 179,900 | SH | | SOLE | | 179,900 | 0 | 0 |
Sarepta Therapeutics, Inc. | Common | 803607100 | 24,340 | 536,600 | SH | | SOLE | | 536,600 | 0 | 0 |
Seattle Genetics, Inc. | Common | 812578102 | 12,172 | 223,700 | SH | | SOLE | | 223,700 | 0 | 0 |
Senior Housing Properties Trust | Shares | 81721M109 | 12,640 | 646,554 | SH | | SOLE | | 646,554 | 0 | 0 |
Shire plc | Sponsored ADR | 82481R106 | 38,609 | 252,113 | SH | | SOLE | | 252,113 | 0 | 0 |
Spark Therapeutics, Inc. | Common | 84652J103 | 2,167 | 24,300 | SH | | SOLE | | 24,300 | 0 | 0 |
SPDR S&P Biotech ETF | S&P Biotech ETF | 78464A870 | 19,605 | 226,460 | SH | | SOLE | | 226,460 | 0 | 0 |
Stryker Corporation | Common | 863667101 | 4,474 | 31,500 | SH | | SOLE | | 31,500 | 0 | 0 |
Syndax Pharmaceuticals, Inc. | Common | 87164F105 | 2,340 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
Tenet Healthcare Corporation | Common | 88033G407 | 2,703 | 164,500 | SH | | SOLE | | 164,500 | 0 | 0 |
TESARO, Inc. | Common | 881569107 | 7,436 | 57,595 | SH | | SOLE | | 57,595 | 0 | 0 |
Tetraphase Pharmaceuticals, Inc. | Common | 88165N105 | 5,878 | 859,322 | SH | | SOLE | | 859,322 | 0 | 0 |
Teva Pharmaceutical Industries Ltd. | Sponsored ADR | 881624209 | 30,915 | 1,756,558 | SH | | SOLE | | 1,756,558 | 0 | 0 |
Thermo Fisher Scientific Inc. | Common | 883556102 | 41,448 | 219,072 | SH | | SOLE | | 219,072 | 0 | 0 |
Trillium Therapeutics Inc. | Common | 89620X506 | 2,575 | 500,000 | SH | | SOLE | | 500,000 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 7,912 | 148,558 | SH | | SOLE | | 148,558 | 0 | 0 |
uniQure N.V. | Shares | N90064101 | 2,314 | 241,021 | SH | | SOLE | | 241,021 | 0 | 0 |
United Therapeutics Corporation | Common | 91307C102 | 5,152 | 43,961 | SH | | SOLE | | 43,961 | 0 | 0 |
UnitedHealth Group Inc. | Common | 91324P102 | 54,021 | 275,826 | SH | | SOLE | | 275,826 | 0 | 0 |
Universal Health Services, Inc. | Class B | 913903100 | 5,334 | 48,076 | SH | | SOLE | | 48,076 | 0 | 0 |
Valeant Pharmaceuticals International, Inc. | Common | 91911K102 | 6,090 | 425,000 | SH | | SOLE | | 425,000 | 0 | 0 |
Ventas, Inc. | Common | 92276F100 | 11,462 | 175,991 | SH | | SOLE | | 175,991 | 0 | 0 |
Verona Pharma plc | Sponsored ADR | 925050106 | 4,221 | 275,000 | SH | | SOLE | | 275,000 | 0 | 0 |
Vertex Pharmaceuticals Incorporated | Common | 92532F100 | 111,160 | 731,123 | SH | | SOLE | | 731,123 | 0 | 0 |
Welltower Inc. | 6.50% Preferred Perpetual | 95040Q203 | 12,686 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
Welltower Inc. | Common | 95040Q104 | 1,504 | 21,400 | SH | | SOLE | | 21,400 | 0 | 0 |
Wright Medical Group N.V. | Ordinary Shares | N96617118 | 6,902 | 266,781 | SH | | SOLE | | 266,781 | 0 | 0 |
Xencor, Inc. | Common | 98401F105 | 458 | 20,000 | SH | | SOLE | | 20,000 | 0 | 0 |
Xenon Pharmaceuticals Inc. | Common | 98420N105 | 1,033 | 350,000 | SH | | SOLE | | 350,000 | 0 | 0 |
Zafgen, Inc. | Common | 98885E103 | 47 | 13,307 | SH | | SOLE | | 13,307 | 0 | 0 |
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 7,939 | 67,800 | SH | | SOLE | | 67,800 | 0 | 0 |